Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis

Eloy E. Ordaya, Elena Beam, Joseph D. Yao, Raymund R. Razonable, Paschalis Vergidis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Characterization of Early-Onset Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients Who Received Tixagevimab-Cilgavimab Prophylaxis'. Together they form a unique fingerprint.

Medicine & Life Sciences